The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Jun. 22, 1999
Filed:
Jun. 07, 1995
Applicant:
Inventors:
Nan-Horng Lin, Mundelein, IL (US);
Mark W Holladay, Libertyville, IL (US);
Melwyn A Abreo, Imperial Beach, CA (US);
David E Gunn, Waukegan, IL (US);
Suzanne A Lebold, Chicago, IL (US);
Richard L Elliott, Grayslake, IL (US);
Yun He, Zion, IL (US);
Assignee:
Abbott Laboratories, Abbott Park, IL (US);
Primary Examiner:
Int. Cl.
CPC ...
C07D / ; C07D / ; C07D / ; A61K / ; A61K / ; A61K / ; A61K / ;
U.S. Cl.
CPC ...
514252 ; 514210 ; 514269 ; 514309 ; 514312 ; 514318 ; 514326 ; 514340 ; 514343 ; 514369 ; 548186 ; 548189 ; 546141 ; 546153 ; 546193 ; 546209 ; 5462681 ; 5462761 ; 546275 ; 546283 ; 544238 ; 544298 ; 544408 ; 544360 ; 544333 ; 544372 ; 544359 ;
Abstract
Novel heterocyclic ether compounds of the formula: ##STR1## wherein *, A,B, n, R.sup.1, R.sup.2 and X are specifically defined, or pharmaceutically-acceptable salts or prodrugs thereof, which are useful in selectively activating or inhibiting neurotransmitter release; to therapeutically-effective pharmaceutical compositions of these compounds; and to the use of said compositions to activate or inhibit neurotransmitter release in mammals.